Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 20:03:21 GMT 2025
by
admin
on
Tue Apr 01 20:03:21 GMT 2025
|
| Protein Type | RECEPTOR |
| Protein Sub Type | NMDA|NMDA RECEPTOR |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
43Q7J075IH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Q13224
Created by
admin on Tue Apr 01 20:03:21 GMT 2025 , Edited by admin on Tue Apr 01 20:03:21 GMT 2025
|
PRIMARY | |||
|
43Q7J075IH
Created by
admin on Tue Apr 01 20:03:21 GMT 2025 , Edited by admin on Tue Apr 01 20:03:21 GMT 2025
|
PRIMARY | |||
|
GRIN2B
Created by
admin on Tue Apr 01 20:03:21 GMT 2025 , Edited by admin on Tue Apr 01 20:03:21 GMT 2025
|
PRIMARY | |||
|
Q13224
Created by
admin on Tue Apr 01 20:03:21 GMT 2025 , Edited by admin on Tue Apr 01 20:03:21 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_60 | 1_295 |
| 1_403 | 1_430 |
| 1_410 | 1_431 |
| 1_720 | 1_775 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_48 |
| N | 1_315 |
| N | 1_322 |
| N | 1_418 |
| N | 1_465 |
| N | 1_516 |
| N | 1_662 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR -> TARGET |
the Ki of PEAQX revealed it only shows a 5 fold difference in affinity for GluN1/GluN2A vs. GluN1/GluN2B receptors. It is also a potent anticonvulsant in animal tests.
COMPETITIVE ANTAGONIST
|
||
|
INHIBITOR -> TARGET |
Potent and selective GluN2B subunit-specific NMDA (N-methyl-D-aspartate) receptor inhibitor.
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET |
|
||
|
INHIBITOR -> TARGET |
Ki
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
NEGATIVE ALLOSTERIC MODULATOR (NAM)->TARGET |
ALLOSTERIC INHIBITOR
IC50
|
||
|
NEGATIVE ALLOSTERIC MODULATOR (NAM)->TARGET |
|
||
|
RADIOLIGAND->TARGET |
Ki
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_856] [1_860] [1_891] [1_894] [1_1032] [1_1035] [1_1038] [1_1117] [1_1229] [1_1233] | DEXFOSFOSERINE | VI4F0K069V |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT | CHEMICAL |
|